These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 14059190)

  • 1. [COMPARATIVE STUDIES ON THE EFFECT OF STREPTOKINASE AND STREPTOKINASE-ACTIVATED PLASMINOGEN IN THROMBOLYTIC THERAPY].
    DEUTSCH E; STACHER A
    Wien Klin Wochenschr; 1963 Sep; 75():667-70. PubMed ID: 14059190
    [No Abstract]   [Full Text] [Related]  

  • 2. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. THROMBOANGIITIS OBLITERANS: WITH SPECIAL REFERENCE TO COAGULATION AND CLOT LYSIS.
    ENDE N
    Vasc Dis; 1964 Mar; 1():83-8. PubMed ID: 14186546
    [No Abstract]   [Full Text] [Related]  

  • 4. TREATMENT OF PERIPHERAL VASCULAR OCCLUSION BY STREPTOKINASE PERFUSION.
    MCNICOL GP; DOUGLAS AS
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:23-9. PubMed ID: 14199705
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteolytic activity of guinea pig serum activated by streptokinase-human plasminogen preparations.
    MEYERS WM; BURDON KL
    Am J Physiol; 1957 Aug; 190(2):303-9. PubMed ID: 13458461
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolytic therapy with streptokinase: a retrospective study.
    Dhall DP; Dawson AA; Mavor GE
    Bibl Anat; 1973; 12():292-6. PubMed ID: 4790363
    [No Abstract]   [Full Text] [Related]  

  • 7. [Considerations on fibrinolysis with special reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1966 Feb; 69(2):255-62. PubMed ID: 4222477
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of lysine and wetting agents on activated plasminogen solutions.
    RICHARD MN; SANDERS BE
    Can J Biochem Physiol; 1963 Jan; 41():211-7. PubMed ID: 13982084
    [No Abstract]   [Full Text] [Related]  

  • 9. [Characterization of various streptokinase dosage schedules through quantitative streptokinase, plasminogen and plasmin determinations in the plasma of patients].
    Büchner U; Martin M; Auel H
    Verh Dtsch Ges Inn Med; 1975; 81():1152-5. PubMed ID: 132799
    [No Abstract]   [Full Text] [Related]  

  • 10. [Further studies on the effect of storage and roentgen irradiation of the fibrinolysin activity of streptokinase-streptodornase in vitro].
    Szirmai E; Berkarda B; Akokan G
    Arzneimittelforschung; 1967 Jan; 17(1):50-2. PubMed ID: 5632527
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coagulation-physiological manifestations and clinical side-effects of streptokinase therapy].
    Vinazzer H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):468-71. PubMed ID: 63434
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of 2000 and 5000 R gamma-ray irradiation on the fibrinolysin-activity of streptokinase-streptodornase.
    Szirmai E; Stamm H
    Haematol Lat; 1966; 9(4):271-7. PubMed ID: 4232520
    [No Abstract]   [Full Text] [Related]  

  • 13. THROMBOEMBOLIC DISEASE IN OBSTETRICS AND GYNECOLOGY.
    JENNINGS JA
    Henry Ford Hosp Med Bull; 1963 Sep; 11():289-307. PubMed ID: 14056322
    [No Abstract]   [Full Text] [Related]  

  • 14. [BIOLOGICAL SURVEILLANCE OF THROMBOLYTIC TREATMENT].
    SAMAMA M; ABASTADO M; PROST RJ; GOGLIN G; CASTEL A; BILSKI-PASQUIER G; SOULIE P; MARCHAL G
    Angeiologie; 1963; 15():25-35. PubMed ID: 14072465
    [No Abstract]   [Full Text] [Related]  

  • 15. [The place of fibrinolytic drugs in the treatment of vascular disorders].
    SALMON J
    Rev Med Liege; 1963 May; 18():316-7. PubMed ID: 13991152
    [No Abstract]   [Full Text] [Related]  

  • 16. [STUDY OF PURIFIED STREPTOKINASE IN ANIMALS].
    JOSSO F
    Angeiologie; 1963; 15():13-5. PubMed ID: 14072463
    [No Abstract]   [Full Text] [Related]  

  • 17. Possibilities for therapy with enzymes.
    SHERRY S
    Ann Otol Rhinol Laryngol; 1959 Mar; 68(1):34-56. PubMed ID: 13627941
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the inhibitory effect of streptokinase on the lytic activity of "spontaneously activated" human plasmin].
    DOLESCHEL W; AUERSWALD W
    Wien Med Wochenschr; 1961 May; 111():306-7. PubMed ID: 13723525
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on hyaline membrane disease. I. The fibrinolysin system in pathogenesis and therapy.
    AMBRUS CM; WEINTRAUB DH; DUNPHY D; DOWD JE; PICKREN JW; NISWANDER KR; AMBRUS JL
    Pediatrics; 1963 Jul; 32():10-24. PubMed ID: 14012535
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasminogen activator formed by reaction of streptokinase with human plasminogen.
    Ts'ao CH; Kline DL
    J Appl Physiol; 1969 May; 26(5):634-9. PubMed ID: 4238461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.